Abstract
Dramatic differences in outcome between early- and late-stage high-grade serous ovarian cancer (HGSC) suggest perhaps distinct genetic origins due to differences in exposures to mutational processes. Evidence to support this hypothesis was recently reported by comparative analysis of copy-number signatures between earlyand late-stage HGSCs.
Cite
CITATION STYLE
APA
Yang, S. Y. C., Pugh, T. J., & Oza, A. M. (2022). Double Trouble: Whole-Genome Doubling Distinguishes Early from Late Ovarian Cancer. Clinical Cancer Research, 28(13), 2730–2732. https://doi.org/10.1158/1078-0432.CCR-22-0336
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free